NCT00954252 - Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Alzheimer's Disease

Interventions

DRUG

CHF 5074

1x, oral capsule, single dose

DRUG

placebo

placebo, oral capsule, single dose

DRUG

CHF 5074

2x, oral capsule, single dose

DRUG

CHF 5074

4x, oral capsule, single dose

DRUG

CHF 5074

8x, oral capsule, single dose

DRUG

CHF 5074

16x, oral capsule, single dose

DRUG

CHF 5074

24x, oral capsule, single dose

Trial Locations (1)

Iberica Clinical Research Center, Eatontown, NJ 07724